Cargando…
Analysis of graft survival in a trial of stem cell transplant in ALS
OBJECTIVE: The first US Food and Drug Administration–approved clinical trial to treat amyotrophic lateral sclerosis (ALS) with neural stem cell–based therapy is in progress. The goal of the current study was to identify and assess the survival of human spinal cord–derived neural stem cells (HSSCs) t...
Autores principales: | Tadesse, Tezeta, Gearing, Marla, Senitzer, David, Saxe, Debra, Brat, Daniel J, Bray, Robert, Gebel, Howard, Hill, Charles, Boulis, Nicholas, Riley, Jonathan, Feldman, Eva, Johe, Karl, Hazel, Thomas, Polak, Meraida, Bordeau, Jane, Federici, Thais, Glass, Jonathan D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265061/ https://www.ncbi.nlm.nih.gov/pubmed/25540804 http://dx.doi.org/10.1002/acn3.134 |
Ejemplares similares
-
Intraspinal Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: Phase 1 Trial Outcomes
por: Feldman, Eva L, et al.
Publicado: (2014) -
Long‐term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS
por: Goutman, Stephen A., et al.
Publicado: (2018) -
Pain in Amyotrophic Lateral Sclerosis: A Neglected Aspect of Disease
por: Handy, Chalonda R., et al.
Publicado: (2011) -
Predicting disease progression in amyotrophic lateral sclerosis
por: Taylor, Albert A., et al.
Publicado: (2016) -
Validation of machine learning models to detect amyloid pathologies across institutions
por: Vizcarra, Juan C., et al.
Publicado: (2020)